SBC Corporation Berhad (KLSE:SBCCORP)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions MYR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 8, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	76	79	92	95	102	102
Market Cap Growth	-14.09%	-14.09%	-4.05%	-6.33%	-	41.07%
Enterprise Value	146	175	197	182	206	206
Last Close Price	0.29	0.30	0.35	0.37	0.40	0.40
PE Ratio	4.42	4.56	308.47	10.16	7.32	31.71
Forward PE	-	6.17	6.17	6.17	6.17	6.17
PS Ratio	1.15	1.20	1.74	1.32	0.88	1.55
PB Ratio	0.18	0.19	0.22	0.23	0.25	0.25
P/TBV Ratio	0.18	0.19	0.23	0.24	0.25	0.26
P/FCF Ratio	4.60	4.79	-	13.09	4.88	-
P/OCF Ratio	4.46	4.65	-	12.40	4.86	-
EV/Sales Ratio	2.21	2.66	3.73	2.51	1.78	3.15
EV/EBITDA Ratio	4.67	5.69	45.33	12.11	7.93	20.90
EV/EBIT Ratio	5.09	6.14	70.41	13.83	8.37	25.17
EV/FCF Ratio	8.87	10.68	-	24.92	9.86	-
Debt / Equity Ratio	0.26	0.26	0.28	0.23	0.23	0.30
Debt / EBITDA Ratio	3.50	3.50	24.91	6.13	3.72	12.22
Debt / FCF Ratio	6.64	6.64	-	12.78	4.62	-
Asset Turnover	0.11	0.11	0.09	0.12	0.19	0.10
Inventory Turnover	0.15	0.15	0.21	0.23	0.30	0.16
Quick Ratio	0.94	0.94	0.97	0.70	0.30	0.20
Current Ratio	2.52	2.52	2.39	2.09	1.89	1.64
Return on Equity (ROE)	4.06%	4.06%	0.32%	2.00%	3.43%	0.65%
Return on Assets (ROA)	3.06%	3.06%	0.30%	1.41%	2.45%	0.77%
Return on Capital (ROIC)	3.37%	3.37%	0.34%	1.62%	2.98%	1.01%
Return on Capital Employed (ROCE)	5.90%	5.90%	0.60%	2.90%	5.40%	1.80%
Earnings Yield	22.82%	21.91%	0.32%	9.84%	13.67%	3.15%
FCF Yield	21.73%	20.87%	-23.05%	7.64%	20.51%	-44.82%
Buyback Yield / Dilution	-	-	-	-	0.02%	-
Total Shareholder Return	-	-	-	-	0.02%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.